It’s time to replenish on maraschino cherries—Pink Dye No. 3 is formally off the market (sorry, Peter Barton Hutt, cherry fanatic and main meals and drug lawyer).
On Jan. 15, 2025, the U.S. Meals and Drug Administration (FDA) banned using Pink Dye No. 3 in meals, drinks, and medicines. Though the company maintains that using the dye is secure and applicable, the ban is a results of a 2022 petition from client advocacy organizations citing an previous, contentious regulation and two research that present that the dye causes most cancers in laboratory male rats. This pressure exists throughout the present regulatory construction: Shoppers concern their meals provide is poisoning them, whereas regulators really feel restricted of their skill to make use of trendy toxicological requirements to judge precise security. After many years of client distrust and company hand-tying, Congress should replace the regulation to permit scientific rules to paved the way in making certain meals security.
The Regulatory Framework for Meals and Coloration Components
FDA regulates the U.S. meals provide beneath the Federal Meals, Drug, and Beauty Act of 1938 (FDCA). Probably the most vital amendments to the FDCA was the addition of the 1958 Meals Components Modification (FAA) and subsequently the 1960 Coloration Components Modification (CAA) (Chapter VII, part 721). Earlier than a coloration additive might be marketed to customers, the company should decide that it’s secure “with cheap certainty of no hurt.” This “basic security clause” within the FDCA requires FDA to think about varied elements together with the possible consumption ranges, cumulative impact of consumption, animal experiment information, and its bodily and chemical properties.
Earlier than voting on the FAA within the Home of Representatives, Congressman Delaney (whose spouse was battling most cancers on the time) insisted that that the invoice embody language—now often known as the Delaney Clause—which requires {that a} meals additive is not going to be permitted by the FDA “whether it is discovered to induce most cancers when ingested by man or animal.” The Delaney Clause was included within the CAA when it was handed a couple of years later. Whereas a seemingly innocuous phrase, this language has come to hang-out FDA. Initially, the company struggled to know how the Delaney Clause restricted its discretion in approving components if a substance didn’t induce most cancers at related doses or meant makes use of. Nevertheless, the main 1987 D.C. Circuit case understood Congress to mean an “terribly inflexible” interpretation of the Delaney Clause to guard the general public from cancer-causing elements. This stays FDA’s interpretation at this time, limiting the company’s skill to approve a meals additive if at any dose—not simply related doses—it’s identified to trigger most cancers in people or animals. Collectively, the FAA, CAA, and Delaney Clause give FDA the authority to assessment the security of meals components earlier than they’ll legally enter the market but in addition significantly limits the company’s discretion on this evaluation.
The Historical past and Way forward for Controversy beneath the Delaney Clause
FD&C Pink No. 3 (“Pink No. 3”) is an artificial dye that’s added to meals to present them a fascinating shiny, cherry-red coloration. It’s usually present in sweet, frostings, and ingested medicine. Below the final security commonplace, Pink No. 3 was permitted to be added to meals within the U.S. market and was “provisionally listed” to be permitted in cosmetics and externally utilized medicine.
But controversy over the additive started shortly after approval. Within the early Nineteen Eighties, the Nationwide Toxicology program started finding out Pink No. 3 in lab animals. Because of early proof displaying ”convincing proof of carcinogenicity in male rats,” in 1990, FDA eradicated the provisionally listed use of the additive, banning its use in topical merchandise. For greater than 35 years, client advocacy teams have continued to check the results of ingested Pink No. 3 in lab animals. Because of this, on Oct. 7, 2023, California banned using Pink No. 3 in any meals product manufactured or bought within the state.
The present controversy over Pink No. 3 highlights the significance of the Delaney Clause. Proponents of the clause argue that regulatory our bodies ought to be unforgiving in the case of elements in our meals and beauty provides that would induce or trigger most cancers at any degree. Client advocacy teams proceed to advance this argument, publicizing varied medical trials in lab animals and organizing mass grassroots campaigns to tell the general public that—beneath particular circumstances—Pink No. 3 has been proven to induce most cancers in animals.
However, FDA and stakeholders argue that the strict literal interpretation of the Delaney Clause inhibits scientific development and unnecessarily undermines belief within the institutional regulatory system. Even within the newest press launch, FDA insists that the ban on Pink No. 3 is merely required by the Delaney Clause in response to the petition—as a matter of regulation—not due to security considerations, noting the organic mechanism by which rats develop most cancers on account of publicity doesn’t happen in people. Whereas lab animal research could also be an inexpensive foundation for taking precautions in some circumstances, the Delaney Clause undermines FDA’s skill to find out for itself whether or not the info presents a “cheap certainty of hurt.”
This pressure begs us to ask whether or not the Delaney Clause is an applicable strategy to decide security of the U.S. meals market. It was launched in 1958 when little was identified concerning the etiology of most cancers and toxicology. Regardless of the well-known sixteenth century phrase from Paracelsus (the great-grandfather of contemporary toxicology) that “the fitting dose differentiates a poison and a treatment,” the Delaney Clause implies that publicity to a chemical with carcinogenic results at some degree presents a critical danger of most cancers at each degree. It’s now properly understood that the growth of most cancers is complicated and multifactorial. Limiting FDA to inflexible, unscientific language might as an alternative be doing extra hurt than good.
Concerning the writer
Jessica Samuels is a third-year twin diploma regulation and public well being pupil (J.D./MPH 2025). Her analysis pursuits embody genetics, environmental well being sciences, novel biotechnologies, and the FDA regulatory course of. She has beforehand revealed work on the accuracy of ultrasound in predicting malignant ovarian plenty. At HLS, Jessica is co-president of the Harvard Well being Regulation Society.